-
2
-
-
33748659432
-
Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy
-
T. Liersch, C. Langer, and B.M. Ghadimi et al. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy J. Clin. Oncol. 24 2006 4062 4068
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 4062-4068
-
-
Liersch, T.1
Langer, C.2
Ghadimi, B.M.3
-
3
-
-
70350446963
-
The dual role of thymidine phosphorylase in cancer development and chemotherapy
-
A. Bronckaers, F. Gago, and J. Balzarini et al. The dual role of thymidine phosphorylase in cancer development and chemotherapy Med. Res. Rev. 29 2009 903 953
-
(2009)
Med. Res. Rev.
, vol.29
, pp. 903-953
-
-
Bronckaers, A.1
Gago, F.2
Balzarini, J.3
-
4
-
-
14044264185
-
DNA mismatch repair-dependent response to fluoropyrimidine-generated damage
-
M. Meyers, M.W. Wagner, and A. Mazurek et al. DNA mismatch repair-dependent response to fluoropyrimidine-generated damage J. Biol. Chem. 280 2005 5516 5526
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 5516-5526
-
-
Meyers, M.1
Wagner, M.W.2
Mazurek, A.3
-
5
-
-
77950521000
-
Mismatch repair deficient colorectal cancer in the era of personalized treatment
-
M. Hewish, C.J. Lord, and S.A. Martin et al. Mismatch repair deficient colorectal cancer in the era of personalized treatment Nat. Rev. Clin. Oncol. 7 2010 197 208
-
(2010)
Nat. Rev. Clin. Oncol.
, vol.7
, pp. 197-208
-
-
Hewish, M.1
Lord, C.J.2
Martin, S.A.3
-
6
-
-
58249088751
-
MicroRNAs: Target recognition and regulatory functions
-
D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
-
(2009)
Cell
, vol.136
, pp. 215-233
-
-
Bartel, D.P.1
-
7
-
-
84885146774
-
Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients
-
M. Jiang, P. Zhang, and G. Hu et al. Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients Mol. Cell Biochem. 2013 67 75
-
(2013)
Mol. Cell Biochem.
, pp. 67-75
-
-
Jiang, M.1
Zhang, P.2
Hu, G.3
-
8
-
-
84878703345
-
MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1
-
C.W. Lin, Y.L. Chang, and Y.C. Chang et al. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 Nat. Commun. 4 2013 1877
-
(2013)
Nat. Commun.
, vol.4
, pp. 1877
-
-
Lin, C.W.1
Chang, Y.L.2
Chang, Y.C.3
-
9
-
-
84881114885
-
MiR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
-
Y. Iwagami, H. Eguchi, and H. Nagano et al. MiR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1 Br. J. Cancer 109 2013 502 511
-
(2013)
Br. J. Cancer
, vol.109
, pp. 502-511
-
-
Iwagami, Y.1
Eguchi, H.2
Nagano, H.3
-
10
-
-
84880947912
-
MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells
-
H.T. Gotanda K, N. Matsumoto, and I. Ieiri MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells BMC Cancer 13 1 2013
-
(2013)
BMC Cancer
, vol.13
, Issue.1
-
-
Gotanda, K.H.T.1
Matsumoto, N.2
Ieiri, I.3
-
11
-
-
84861726425
-
Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues
-
T. Hirota, Y. Date, and Y. Nishibatake et al. Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues Lung Cancer 77 2012 16 23
-
(2012)
Lung Cancer
, vol.77
, pp. 16-23
-
-
Hirota, T.1
Date, Y.2
Nishibatake, Y.3
-
12
-
-
84880958993
-
MicroRNA-21 promotes ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro
-
W.M. Chung, W.C. Chang, and L. Chen et al. MicroRNA-21 promotes ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro Stem Cell Res. Ther. 4 2013 88
-
(2013)
Stem Cell Res. Ther.
, vol.4
, pp. 88
-
-
Chung, W.M.1
Chang, W.C.2
Chen, L.3
-
13
-
-
84902131776
-
The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21
-
C. Soria-Valles, A. Gutierrez-Fernandez, and M. Guiu et al. The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21 Oncogene 2013
-
(2013)
Oncogene
-
-
Soria-Valles, C.1
Gutierrez-Fernandez, A.2
Guiu, M.3
-
14
-
-
84883479886
-
AC1MMYR2, an inhibitor of Dicer-mediated biogenesis of oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression
-
Z. Shi, J. Zhang, and X. Qian et al. AC1MMYR2, an inhibitor of Dicer-mediated biogenesis of oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression Cancer Res. 2013 5519 5531
-
(2013)
Cancer Res.
, pp. 5519-5531
-
-
Shi, Z.1
Zhang, J.2
Qian, X.3
-
15
-
-
84855389885
-
MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells
-
Y. Yu, S.S. Kanwar, and B.B. Patel et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells Carcinogenesis 33 2012 68 76
-
(2012)
Carcinogenesis
, vol.33
, pp. 68-76
-
-
Yu, Y.1
Kanwar, S.S.2
Patel, B.B.3
-
16
-
-
39049128249
-
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer
-
O. Slaby, M. Svoboda, and P. Fabian et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer Oncology 72 2007 397 402
-
(2007)
Oncology
, vol.72
, pp. 397-402
-
-
Slaby, O.1
Svoboda, M.2
Fabian, P.3
-
17
-
-
77953767473
-
Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases
-
V. Kulda, M. Pesta, and O. Topolcan et al. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases Cancer Genet. Cytogenet. 200 2010 154 160
-
(2010)
Cancer Genet. Cytogenet.
, vol.200
, pp. 154-160
-
-
Kulda, V.1
Pesta, M.2
Topolcan, O.3
-
18
-
-
78149469070
-
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells
-
Y. Tomimaru, H. Eguchi, and H. Nagano et al. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells Br. J. Cancer 103 2010 1617 1626
-
(2010)
Br. J. Cancer
, vol.103
, pp. 1617-1626
-
-
Tomimaru, Y.1
Eguchi, H.2
Nagano, H.3
-
19
-
-
67749110399
-
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
-
M. Seike, A. Goto, and T. Okano et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers Proc. Natl. Acad. Sci. U. S. A. 106 2009 12085 12090
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 12085-12090
-
-
Seike, M.1
Goto, A.2
Okano, T.3
-
20
-
-
84863534138
-
MicroRNA-21 expression is regulated by beta-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK
-
L. Han, X. Yue, and X. Zhou et al. MicroRNA-21 expression is regulated by beta-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK CNS Neurosci. Ther. 18 2012 573 583
-
(2012)
CNS Neurosci. Ther.
, vol.18
, pp. 573-583
-
-
Han, L.1
Yue, X.2
Zhou, X.3
-
21
-
-
34247495591
-
MiR-21-mediated tumor growth
-
M.L. Si, S. Zhu, and H. Wu et al. MiR-21-mediated tumor growth Oncogene 26 2007 2799 2803
-
(2007)
Oncogene
, vol.26
, pp. 2799-2803
-
-
Si, M.L.1
Zhu, S.2
Wu, H.3
-
22
-
-
79956313718
-
Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer
-
C. Gong, Y. Yao, and Y. Wang et al. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer J. Biol. Chem. 286 2011 19127 19137
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 19127-19137
-
-
Gong, C.1
Yao, Y.2
Wang, Y.3
-
23
-
-
33744521896
-
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
-
F. Meng, R. Henson, and M. Lang et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines Gastroenterology 130 2006 2113 2129
-
(2006)
Gastroenterology
, vol.130
, pp. 2113-2129
-
-
Meng, F.1
Henson, R.2
Lang, M.3
-
24
-
-
77954509251
-
Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
-
G.H. Shi, D.W. Ye, and X.D. Yao et al. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells Acta Pharmacol. Sin. 31 2010 867 873
-
(2010)
Acta Pharmacol. Sin.
, vol.31
, pp. 867-873
-
-
Shi, G.H.1
Ye, D.W.2
Yao, X.D.3
-
25
-
-
84871955958
-
Proteasome inhibition rescues clinically significant unstable variants of the mismatch repair protein Msh2
-
S.K. Arlow T, A. Wagenseller, and A. Gammie Proteasome inhibition rescues clinically significant unstable variants of the mismatch repair protein Msh2 Proc. Natl. Acad. Sci. U. S. A. 110 1 2013 246 251
-
(2013)
Proc. Natl. Acad. Sci. U. S. A.
, vol.110
, Issue.1
, pp. 246-251
-
-
Arlow, T.S.K.1
Wagenseller, A.2
Gammie, A.3
-
26
-
-
84860605783
-
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study
-
A.K. Win, J.P. Young, and N.M. Lindor et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study J. Clin. Oncol. 30 2012 958 964
-
(2012)
J. Clin. Oncol.
, vol.30
, pp. 958-964
-
-
Win, A.K.1
Young, J.P.2
Lindor, N.M.3
-
27
-
-
84883476808
-
Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity
-
A. Kothandapani, A. Sawant, and V.S. Dangeti et al. Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity Nucleic Acids Res. 41 2013 7332 7343
-
(2013)
Nucleic Acids Res.
, vol.41
, pp. 7332-7343
-
-
Kothandapani, A.1
Sawant, A.2
Dangeti, V.S.3
-
28
-
-
78650500590
-
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
-
G.P. Valeri N, C. Braconi, and A. Paone et al. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) Proc. Natl. Acad. Sci. U. S. A. 107 2010 21098 21103
-
(2010)
Proc. Natl. Acad. Sci. U. S. A.
, vol.107
, pp. 21098-21103
-
-
Valeri, N.G.P.1
Braconi, C.2
Paone, A.3
-
29
-
-
40849142340
-
The clinical significance of splice variants and subcellular localisation of surviving in non-small cell lung cancers
-
J. Nakano, C. Huang, and D. Liu et al. The clinical significance of splice variants and subcellular localisation of surviving in non-small cell lung cancers Br. J. Cancer 98 2008 1109 1117
-
(2008)
Br. J. Cancer
, vol.98
, pp. 1109-1117
-
-
Nakano, J.1
Huang, C.2
Liu, D.3
-
30
-
-
20444363802
-
Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer - In correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase
-
K. Inoue, M. Takao, and F. Watanabe et al. Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer - in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase Lung Cancer 49 2005 47 54
-
(2005)
Lung Cancer
, vol.49
, pp. 47-54
-
-
Inoue, K.1
Takao, M.2
Watanabe, F.3
|